Review of methods for assessing the cost-effectiveness of medical interventions
Assessment of the effectiveness of a drug is a complex process. Currently, the standard method for assessing the effectiveness of a medical intervention is the quality-adjusted life years (QALY). In the summer of 2024, a description of a new method for assessing the effectiveness of medical interven...
Saved in:
| Main Authors: | T. I. Busheva, A. A. Kurylev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Publishing House OKI
2025-01-01
|
| Series: | Реальная клиническая практика: данные и доказательства |
| Subjects: | |
| Online Access: | https://www.myrwd.ru/jour/article/view/79 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of RWD / RWE in health technology assessment
by: V. G. Borovskaya, et al.
Published: (2023-03-01) -
Surrogate endpoints in cost-effectiveness analysis for use in medical technology assessment
by: T. I. Busheva, et al.
Published: (2025-07-01) -
Crossing borders: the need for empirical evidence of real-world evidence transportability in oncology
by: Caitlin Clunie-O’Connor, et al.
Published: (2025-07-01) -
RETRACTED: ESMO Guidance for reporting oncology real-world evidence (GROW)
by: A. Sh. Motrinchuk, et al.
Published: (2024-04-01) -
STaRT-RWE: structured template for planning and reporting on the implementation of real-world evidence studies
by: S. L. Plavinskij, et al.
Published: (2022-11-01)